Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A

May 2023
Vol-9, Issue-3
Paper ID: 20344
ISSN: 2395-4396
Downloads: 107
Download PDF

Abstract & Details

Research Area
life Sciences
Keywords
Hemophilia A Gene Therapy FIII Valoctocogene Roxaparvovec (Roctavian) Adeno-Associated Virus (AAV) BioMarin Pharmaceutical Inc
Abstract
Hemophilia is a hemorrhagic disease characterized by the absence or deficiency of clotting factor VIII (hemophilia A) or clotting factor IX (hemophilia B) and hemophilia C or factor XI deficiency. It affects 1 in 5,000 living males, 1 in 40,000 live males, and 1 in 100,000 live births worldwide (Hemophilia A, B, and C). Emicizumab is a monoclonal antibody that bridges activated factors IX and X to perform the duties of activated factor VIII when it is absent, restoring hemostasis. Intravenous infusion of exogenous FVIII is the current gold standard in hemophilia A treatment. Prophylactic coagulation factor replacement has been shown to reduce arthropathy, decrease the frequency of bleeds, and improve quality of life. Gene therapy for hemophilia involves targeting hepatocytes, allowing for long-term expression of defective FVIII while maintaining stable plasma FVIII concentrations. The first gene therapy for hemophilia A is Roctavian. Valoctocogene roxaparvovec, the active ingredient in Roctavian, is based on an adeno-associated virus (AAV) that has been altered not to infect people. Roxaparvovec was granted conditional marketing authorization in the EU to treat severe hemophilia A in adults without FVIII inhibitors and AAV5 antibodies.

Author Information

# Name Institute / Affiliation
1 Sanaullah Safi Cheragh Medical Institute of Higher Education
2 Hedayaturahman Habibzai Mili Institute of Higher Education
3 sayed tariq Pachakhan Spinghar Medical Institute

How to Cite

Use the following formats to cite this article in your research.

APA Style
Safi, Sanaullah, Habibzai, Hedayaturahman, & Pachakhan, sayed tariq (2023). Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A. International Journal of Advance Research and Innovative Ideas In Education, 9(3), 2150-2157.
MLA Style
Safi, Sanaullah, et al. "Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A." International Journal of Advance Research and Innovative Ideas In Education, vol. 9, no. 3, 2023, pp. 2150-2157.
IEEE Style
Sanaullah Safi, Hedayaturahman Habibzai, and sayed tariq Pachakhan, "Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A," International Journal of Advance Research and Innovative Ideas In Education, vol. 9, no. 3, pp. 2150-2157, 2023.
Vancouver Style
Safi Sanaullah, Habibzai Hedayaturahman, Pachakhan sayed tariq. Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A. International Journal of Advance Research and Innovative Ideas In Education. 2023;9(3):2150-2157.
Harvard Style
Safi, Sanaullah, Habibzai, Hedayaturahman, & Pachakhan, sayed tariq (2023) 'Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A', International Journal of Advance Research and Innovative Ideas In Education, 9(3), pp. 2150-2157.
Chicago Style
Safi, Sanaullah, Hedayaturahman Habibzai, and sayed tariq Pachakhan. "Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A." International Journal of Advance Research and Innovative Ideas In Education 9, no. 3 (2023): 2150-2157.
Turabian Style
Safi, Sanaullah, Hedayaturahman Habibzai, and sayed tariq Pachakhan. "Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A." International Journal of Advance Research and Innovative Ideas In Education 9, no. 3 (2023): 2150-2157.

Export Citation

Related Research

Polycystic Ovary Syndrome Prediction [ML]
Chavan Ganesh Baban et al. 2023 Information Technology Engineering
Download PDF
Role of Nutrition in Chronic Kidney Disease
Ms. Tanvi Sunil Ballal et al. 2023 Food science and Nutraceutical
Download PDF
NANOMEDICINES IN NANOTECHNOLOGY
Mohammad Shoab Shaikh Diler et al. 2023 Pharmacy
Download PDF